Correction
Published on 14 Dec 2023
Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1345663
- 726 views
- 4 citations
Type at least 3 characters
2,597 articles
Articles
Systematic Review
Published on 14 Dec 2023
Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1330877
- 2,054 views
- 3 citations
Original Research
Published on 14 Dec 2023
Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1286061
- 6,041 views
- 3 citations
Mini Review
Published on 14 Dec 2023
Research progress of biomineralization for the diagnosis and treatment of malignant tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1335019
- 1,140 views
Original Research
Published on 13 Dec 2023
Iberverin exhibits antineoplastic activities against human hepatocellular carcinoma via DNA damage-mediated cell cycle arrest and mitochondrial-related apoptosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1326346
- 1,572 views
- 1 citation
Case Report
Published on 12 Dec 2023
Lichenoid mucocutaneous reactions associated with sintilimab therapy in a non-small cell lung adenocarcinoma patient: case report and review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1276788
- 1,197 views
- 1 citation
Original Research
Published on 12 Dec 2023
NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1295422
- 1,525 views
Case Report
Published on 11 Dec 2023
Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203N
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1197163
- 1,258 views
- 1 citation
Original Research
Published on 11 Dec 2023
Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1260683
- 1,558 views
- 1 citation
Review
Published on 08 Dec 2023
Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1292088
- 2,773 views
- 7 citations
Original Research
Published on 07 Dec 2023
Discovery of potential WEE1 inhibitors via hybrid virtual screening
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1298245
- 2,239 views
- 1 citation
Original Research
Published on 07 Dec 2023
PdMo nanoflowers for endogenous/exogenous-stimulated nanocatalytic therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1324764
- 1,024 views
- 1 citation
Mini Review
Published on 07 Dec 2023
Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1322937
- 5,819 views
- 3 citations
Retraction
Published on 07 Dec 2023
Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1349235
- 1,116 views
Original Research
Published on 06 Dec 2023
Preparation and investigation of a novel combination of Solanum nigrum-loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: in vitro, in vivo, and in silico evaluation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1325498
- 2,038 views
- 2 citations
Original Research
Published on 06 Dec 2023
Pre- and post-chemotherapy spermatogenesis in male patients with malignant bone and soft tissue tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1324339
- 963 views